Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

28.62
-0.2550-0.88%
Post-market: 28.46-0.1550-0.54%16:13 EDT
Volume:3.32M
Turnover:94.57M
Market Cap:3.21B
PE:-24.81
High:29.01
Open:28.91
Low:27.69
Close:28.87
Loading ...
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 22, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2024

Major Issues Report

Form 8-K - Current report
Mar 26, 2024

Major Issues Report

Form 8-K - Current report
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 07, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 07, 2024

Major Issues Report

Form 8-K - Current report